Cite
HARVARD Citation
Dropulic, L. et al. (n.d.). A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals. Open forum infectious diseases. pp. S415-S416. [Online].